Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.83M | 31.25M | 35.86M | 38.26M | 43.35M |
| Total Receivables | 750.00K | 1.80M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.03M | 1.53M | 1.84M | 3.72M | 4.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.62M | 34.58M | 37.69M | 41.98M | 47.56M |
|
|
|||||
| Total Current Assets | 28.62M | 34.58M | 37.69M | 41.98M | 47.56M |
| Net Property, Plant & Equipment | 167.00K | 210.00K | 278.00K | 344.00K | 413.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 174.00K | 192.00K | 210.00K | 228.00K | 245.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.00K | 22.00K | 19.00K | 21.00K | 23.00K |
| Total Assets | 28.98M | 35.00M | 38.20M | 42.57M | 48.24M |
|
|
|||||
| Total Accounts Payable | 602.00K | 1.28M | 556.00K | 728.00K | 1.26M |
| Total Accrued Expenses | 3.11M | 4.19M | 3.95M | 3.55M | 3.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 92.00K | 137.00K | 181.00K | 176.00K | 172.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.81M | 5.61M | 4.69M | 4.46M | 5.33M |
|
|
|||||
| Total Current Liabilities | 3.81M | 5.61M | 4.69M | 4.46M | 5.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 47.00K | 92.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Total Liabilities | 3.88M | 5.69M | 4.76M | 4.58M | 5.50M |
|
|
|||||
| Common Stock & APIC | 578.93M | 578.43M | 577.89M | 577.56M | 577.29M |
| Retained Earnings | -552.79M | -548.07M | -543.46M | -538.53M | -533.48M |
| Treasury Stock & Other | -786.00K | -789.00K | -740.00K | -785.00K | -812.00K |
| Total Common Equity | 25.36M | 29.57M | 33.69M | 38.25M | 43.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.36M | 29.57M | 33.69M | 38.25M | 43.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K |
| Total Equity | 25.10M | 29.32M | 33.44M | 38.00M | 42.74M |
|
|
|||||